We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 5 of 9
Most popular |Most recent

Lack of Evidence of Efficacy Invalidates Patent on Combination Drug

USA - May 15 2019 Written description is not satisfied when the claimed drug is understood to be ineffective by a person skilled in the art and the description...

Yinan Lin, Ph.D..

Neptune Generics, LLC, Fresenius Kabi USA, LLC v. Eli Lilly & Co.

USA - April 29 2019 Before Moore, Wallach, and Hughes. Appeal from the Patent Trial and Appeal Board Summary: Industry skepticism is a question of fact that weighs in...

Alexander Zeng.

Secondary Consideration of Skepticism Supports Non-Obviousness at PTAB

USA - April 29 2019 Industry skepticism is a question of fact that weighs in favor of non-obviousness and can range on a scale, with the most weight afforded to...

Alexander Zeng.

Sri International, Inc. v. Cisco Systems, Inc.

USA - March 21 2019 Under step one of Alice, a claim is not directed to an abstract idea when it recites a specific technique to solve a technological problem arising in...

Noorean Gill.

Continental Circuits LLC v. Intel Corporation

USA - February 8 2019 Reading a process limitation into a product claim is improper where the patentee did not clearly and unmistakably disavow claim scope and also did...

Josepher Li.